The FDA investigated bottles of Diocto Liquid that were collected from these medical centers. Investigators found that collected bottles contained total aerobic microbial counts and total yeast and mold counts over acceptable limits. Some of the bottles also tested positive for B. cepacia. These bottles were from the same lot distributed by PharmaTech in March 2017, and were not disclosed by Figueroa, accoprding to the indictment.
Figueroia faced the charges against him during his initial appearance in the federal magistrate court in Fort Lauderdale, Florida. ‘
The U.S. Attorney’s Office for the Southern District of Florida announced the charges against the defendant.
Have a story you want USA Herald to cover? Submit a tip here and if we think it’s newsworthy, we’ll follow up on it.
Want to contribute a story? We also accept article submissions – check out our writer’s guidelines here.
